Nelson Textbook of Pediatrics 22nd Edition | Comprehensive coverage: Rhabdomyosarcoma (embryonal 60%, alveolar 25-40%, PAX-FOXO1 fusion), risk stratification, treatment (VAC, VDC/IE), late effects. Non-rhabdomyosarcoma soft tissue sarcomas (NRSTS): synovial sarcoma (SS18-SSX), infantile fibrosarcoma (ETV6-NTRK3 → larotrectinib), MPNST (NF1), alveolar soft part sarcoma (ASPSCR1-TFE3).
🌐 paeds.online — Pakistan's Pediatric Platform